Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV infection in the era of highly active antiretroviral therapy: the Malaga Study.
Santos J, Palacios R, Gutierrez M, Grana M, de la Torre J, Salgado F, Nuño E, Márquez M; Grupo Malagueño para el estudio de Enfermedades Infecciones. Santos J, et al. Among authors: marquez m. Int J STD AIDS. 2004 Sep;15(9):594-6. doi: 10.1258/0956462041724253. Int J STD AIDS. 2004. PMID: 15339366
Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment.
Mira JA, Lozano F, Santos J, Ramayo E, Terrón A, Palacios R, León EM, Márquez M, Macías J, Fernández-Palacin A, Gómez-Mateos J, Pineda JA; Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Mira JA, et al. Among authors: marquez m. Antivir Ther. 2004 Aug;9(4):511-7. Antivir Ther. 2004. PMID: 15456082 Clinical Trial.
[Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Málaga (Spain)].
Palacios R, Viciana I, Pérez de Pedro I, de la Torre J, Ropero F, Fernández S, Salgado F, Roldán J, de Dios Colmenero J, Márquez M, Santos J; Grupo Malagueño para el Estudio de las Enfermedades Infecciosas. Palacios R, et al. Among authors: marquez m. Enferm Infecc Microbiol Clin. 2008 Mar;26(3):141-5. doi: 10.1157/13116750. Enferm Infecc Microbiol Clin. 2008. PMID: 18358212 Spanish.
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.
Macías J, Orihuela F, Rivero A, Viciana P, Márquez M, Portilla J, Ríos MJ, Muñoz L, Pasquau J, Castaño MA, Abdel-Kader L, Pineda JA; Hepatip Study Group. Macías J, et al. Among authors: marquez m. J Antimicrob Chemother. 2009 Jan;63(1):178-83. doi: 10.1093/jac/dkn429. Epub 2008 Oct 24. J Antimicrob Chemother. 2009. PMID: 18952618
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C.
Macías J, Neukam K, Portilla J, Iribarren JA, de Los Santos I, Rivero A, Márquez M, Delgado M, Téllez F, Merino D, Giner L, von Wichmann MA, Pineda JA; HEPRAL study team. Macías J, et al. Among authors: marquez m. J Antimicrob Chemother. 2011 Jun;66(6):1346-50. doi: 10.1093/jac/dkr083. Epub 2011 Mar 10. J Antimicrob Chemother. 2011. PMID: 21398295
1,164 results